dupixent eczema treatment - Yahoo Search Results

- Sanofi's Dupixent gets U.S. approval to treat eczema in young children
  Reuters via Yahoo News· 1 year ago
  Dupixent is now the first approved treatment for moderate-to-severe eczema in young children, Sanofi...
- Danielle Jonas says her eczema affected her self-esteem and deterred her from going on tour often...
  INSIDER via Yahoo News· 2 months ago
  Danielle Jonas opened up about her eczema journey in a recent interview with Insider.Courtesy of...
- Sanofi's (SNY) Dupixent Gets FDA Nod for Eczema in Infants
  Zacks via Yahoo Finance· 1 year ago
  Sanofi (SNY) and partner Regeneron's label expansion application for Dupixent to include infants...
- Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
  Benzinga via Yahoo Finance· 1 year ago
  The FDA approved Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA's (NASDAQ: SNY) Dupixent...
- Why Tech Leader Regeneron Shouldn't Sweat Its AbbVie Rival — For Now
  Investor's Business Daily· 1 year ago
  AbbVie could soon pressure Regeneron Pharmaceuticals in eczema treatment, an analyst said Friday as...
- Eczema and the COVID-19 Vaccine: Is it Safe?
  Verywell Health via Yahoo News· 11 months ago
  COVID-19 vaccines are safe for people who have eczema, an itchy rash that is the most common type of atopic dermatitis. The COVID-19 vaccines available...
- What Is Baby Eczema?
  Health via Yahoo News· 2 months ago
  Baby eczema is an umbrella term for different types of dermatitis. Eczema can develop in infants as young as two months old. Most cases of eczema occur...
- Pharma Stock Roundup: SNY's COPD Study Meets Goal, ABBV Parkinson's Drug Gets CRL
  Zacks via Yahoo Finance· 6 months ago
  This week, Sanofi SNY and partner Regeneron’s REGN blockbuster medicine, Dupixent succeeded in a...
- Sanofi Scores A Big Beat As Dupixent Snags The Spotlight, Again
  Investor's Business Daily· 1 year ago
  Sanofi stock inched higher Thursday after the Swiss pharma giant beat Wall Street's quarterly views...
- Regeneron Breaks Out On Home Run In 'Smoker's Lung' As Sanofi Soars
  Investor's Business Daily· 6 months ago
  Sanofi and Regeneron Pharmaceuticals' asthma drug Dupixent succeeded in a final-phase study of...